Consensus HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Real-time Estimate Cboe BZX 03:19:55 2024-05-03 pm EDT 5-day change 1st Jan Change
309.4 USD +0.19% Intraday chart for HCA Healthcare, Inc. +0.90% +14.32%

Evolution of the average Target Price on HCA Healthcare, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1149577c1c06eaa19855bf56273fd6c8.X4NugBdn1tnYhr5OozCc4J9LGqtkbuXHXnkBCpu_hQo.Hs4B6HQA546r0vIU90Dw0q4ZXOVRCYGLKzhIeMn33UsM2T_qclXuvLD_1Q~7a6535ef16af1b31e4027e7d835ce36d
TD Cowen Adjusts Price Target on HCA Healthcare to $360 From $371 MT
Leerink Partners Adjusts Price Target on HCA Healthcare to $367 From $354 MT
UBS Adjusts HCA Healthcare Price Target to $363 From $348, Maintains Buy Rating MT
RBC Capital Adjusts Price Target on HCA Healthcare to $329 From $322 MT
Oppenheimer Adjusts HCA Healthcare Price Target to $345 From $330, Maintains Outperform Rating MT
Barclays Adjusts HCA Healthcare's Price Target to $367 From $356, Keeps Overweight Rating MT
Mizuho Adjusts Price Target on HCA Healthcare to $370 From $345 MT
Truist Securities Adjusts Price Target on HCA Healthcare to $375 From $345 MT
Deutsche Bank Adjusts HCA Healthcare Price Target to $359 From $330, Maintains Buy Rating MT
Wells Fargo Raises Price Target on HCA Healthcare to $315 From $303, Maintains Equalweight Rating MT
ANALYST RECOMMENDATIONS : Nasdaq, Stellantis, Clorox, Ulta Beauty, Standard Chartered... Our Logo
Hca Healthcare Insider Sold Shares Worth $400,057, According to a Recent SEC Filing MT
ANALYST RECOMMENDATIONS : Doordash, Microsoft, Roblox, Uber, Redrow... Our Logo
UBS Adjusts HCA Healthcare Price Target to $348 From $305, Maintains Buy Rating MT
Deutsche Bank Raises HCA Healthcare Price Target to $330 From $280, Maintains Buy Rating MT
Raymond James Raises Price Target on HCA Healthcare to $330 From $300, Maintains Outperform Rating MT
Oppenheimer Raises HCA Healthcare Price Target to $330 From $315, Maintains Outperform Rating MT
RBC Raises Price Target on HCA Healthcare to $322 From $308 Amid 'Impressive' Q4 Results, 2024 Guidance; Outperform Kept MT
RBC Raises Price Target on HCA Healthcare to $308 From $284, Keeps Outperform Rating MT
Bernstein Downgrades HCA Healthcare to Market Perform From Outperform, Price Target is $301 MT
Goldman Sachs Downgrades HCA Healthcare to Neutral From Buy, Cuts Price Target to $271 From $281 MT
Argus Cuts HCA Healthcare Price Target to $290 From $310, Maintains Buy Rating MT
JPMorgan Adjusts Price Target on HCA Healthcare to $265 From $313, Maintains Neutral Rating MT
ANALYST RECOMMENDATIONS : Best Buy, Diageo, Eli Lilly, Estee Lauder, Home Depot... Our Logo
Goldman Sachs Cuts Price Target on HCA Healthcare to $281 From $329, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
308.8 USD
Average target price
344.4 USD
Spread / Average Target
+11.50%
High Price Target
378 USD
Spread / Highest target
+22.39%
Low Price Target
285 USD
Spread / Lowest Target
-7.72%

Consensus detail

Consensus revision (last 18 months)

Analysts covering HCA Healthcare, Inc.

TD Cowen
Leerink Partners
UBS
RBC Capital Markets
Oppenheimer
Barclays
Mizuho Securities
Truist Securities
Deutsche Bank Securities
Wells Fargo Securities
Raymond James
Bernstein
Goldman Sachs
Argus
JPMorgan Chase
Stephens Inc.
Baptista Research
Credit Suisse
Jefferies & Co.
Citigroup
BofA Securities
Loop Capital
Cantor Fitzgerald
Cowen
SVB Securities LLC
BMO Capital
SVB Leerink
Seaport Global Securities
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock Market
  2. Equities
  3. HCA Stock
  4. Consensus HCA Healthcare, Inc.